FDA approves Besivance for bacterial conjunctivitis
The FDA has approved a new antibacterial eyedrop called Besivance for the treatment of a contagious eye infection called bacterial conjunctivitis, commonly known as “pinkeye.” Symptoms of bacterial conjunctivitis include red eyes, swelling, eyelids sticking together, itching, watering, and a white or yellow sticky discharge from the eyes. Bacterial conjunctivitis generally runs its course in seven to 14 days. Although this infection is common among kids, it can also affect people of other ages.
- Bausch & Lomb’s pink eye drug likely to get FDA recommendation
- Production of AzaSite increased by InSite Vision Inc and Inspire
- FDA Recommends Approval for Ophthalmic Product Enabled By InSite’s DuraSite® Technology
- FDA approves Hi-Tech Pharmacal’s generic ophthalmic solution
